The protein encoded by the rat brain cDNA 1B236 has been shown to be identical to myelin-associated glycoprotein (MAG). In this report we describe the cellular distribution of 1B236/MAG mRNA transcripts in rat brain by using in situ hybridization. At postnatal day 20, large numbers of 1B236/MAG mRNA-containing oligodendrocytes are concentrated in myelinated fiber tracts and throughout gray matter regions. The presence of high levels of 1B236/MAG mRNA within oligodendrocytes at postnatal day 20 is consistent with the proposed role of MAG in formation of the myelin sheath during development. In the adult brain, our results suggest that not only is 1B236/MAG mRNA expressed at reduced levels within oligodendrocytes but also 1B236/MAG or a lB236/MAG-like mRNA is present within neurons. This localization is consistent with the results of previous immunocytochemical studies using antibodies against the 1B236 protein. The apparent developmental profile of 1B236/MAG mRNA with different cell-type-specific patterns of expression suggests that oligodendrocytes and neurons employ different mechanisms for regulating the same gene. Thus, different cell types may use a similar cell adhesion molecule both during myelinogenesis and in the mature nervous system. Myelin-associated glycoprotein (MAG), a constituent of myelin in both peripheral and central nervous systems (CNS), appears to act as a cell adhesion molecule between glia and neurons (1, 2) and may be involved in formation of the periaxonal space (3). Molecular cloning studies (4-6) have shown that MAG is identical to the rat brain protein 1B236, previously defined by characterization of "brainspecific" mRNAs (7). The single 1B236/MAG gene gives rise to several mRNAs by alternative RNA splicing (4); the omission or inclusion ofexon 12 ofthe gene results in mRNAs encoding polypeptides with different carboxyl-terminal sequences and molecular masses of72 and 67 kDa, respectively (4, 5). During development, 1B236/MAG accumulates in the rat CNS until approximately postnatal day (PD) 20, by which time myelination has largely been completed (1). Similarly, the steady-state level of 1B236 mRNA increases until PD 15-25 and drops in the adult to 20% ofthe maximal levels attained during development (8). This developmental change in 1B236/MAG abundance appears to be accompanied by a transition in expression of the alternatively spliced mRNAs and their products: the 72-kDa form is expressed during postnatal development and myelinogenesis, whereas the 67-kDa form predominates in the adult (4, 9).Immunocytochemistry has been used to demonstrate the presence of MAG within oligodendrocytes in both developing and adult CNS (3, 10), consistent with its proposed role in formation of the myelin sheath. However, anti-MAG antibodies have been reported to stain a variety ofother cell types (11-15), including neurons (16, 17). Using antibodies generated against synthetic peptides derived from the 1B236 cDNA sequence, we have also detected 1B236/MAG immunoreactivity within subpopulations o...